I agree that this site is using cookies. You can find further informations here.
X
Christoph, Losem
41  results:
Search for persons X
?
1

PB1938: REAL WORLD EFFECTIVENESS AND SAFETY OF VENETOCLAX I..:

Schwaner, Ingo ; Hebart, Holger ; Christoph, Losem...
HemaSphere.  7 (2023)  S3 - p. e5034942 , 2023
Link: https://doi.org/10.1097/..
 
?
2

Low incidence of tumor lysis syndrome in elderly patients w..:

Schwaner, Ingo ; Kuhn, Thomas ; Losem, Christoph...
Annals of Hematology.  103 (2024)  6 - p. 2013-2020 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Patient‐reported outcomes in advanced NSCLC before and duri..:

Sebastian, Martin ; Eberhardt, Wilfried E. E. ; von der Heyde, Eyck...
International Journal of Cancer.  154 (2024)  11 - p. 1967-1978 , 2024
Link: https://doi.org/10.1002/..
 
?
4

P649: SAFETY AND EFFECTIVENESS IN NAIVE CLL PATIENTS TREATE..:

Ingo, Schwaner ; Hebart, Holger ; Losem, Christof...
HemaSphere.  7 (2023)  S3 - p. e284175f , 2023
Link: https://doi.org/10.1097/..
 
?
5

Real-world patient-reported outcomes of breast cancer or pr..:

Jakob, Andreas ; Zahn, Mark-Oliver ; Nusch, Arnd...
Journal of Bone Oncology.  33 (2022)  - p. 100420 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Biomarker testing in non-small cell lung cancer in routine ..:

Griesinger, Frank ; Eberhardt, Wilfried ; Nusch, Arnd...
Lung Cancer.  152 (2021)  - p. 174-184 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Corrigendum to "Biomarker testing in non-small cell lung ca..:

Griesinger, Frank ; Eberhardt, Wilfried ; Nusch, Arnd...
Lung Cancer.  157 (2021)  - p. 167 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Nintedanib Plus Docetaxel After Progression on Immune Check..:

Grohé, Christian ; Gleiber, Wolfgang ; Haas, Siegfried...
Future Oncology.  15 (2019)  23 - p. 2699-2706 , 2019
Link: https://doi.org/10.2217/..
 
?
9

AVAiLABLE NIS – AVASTIN® in lung cancer treatment in routin..:

Zahn, Mark-Oliver ; Linck, Dominik ; Losem, Christoph...
BMC Cancer.  19 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
10

Impact of performance status and transfusion dependency on ..:

Wehmeyer, Jürgen ; Zaiss, Matthias ; Losem, Christoph...
European Journal of Haematology.  101 (2018)  6 - p. 766-773 , 2018
Link: https://doi.org/10.1111/..
 
?
11

Prophylaxis of chemotherapy‐induced neutropenia and febrile..:

Wolff, Thomas ; Schulz, Holger ; Losem, Christoph...
European Journal of Haematology.  102 (2018)  2 - p. 174-181 , 2018
Link: https://doi.org/10.1111/..
 
?
12

Lenalidomide plus dexamethasone for patients with relapsed ..:

Knauf, Wolfgang ; Aldaoud, Ali ; Losem, Christoph...
Leukemia Research.  68 (2018)  - p. 90-97 , 2018
Link: https://doi.org/10.1016/..
 
?
13

Biosimilar Retacrit® (epoetin zeta) in the treatment of che..:

Losem, Christoph ; Koenigsmann, Michael ; Rudolph, Christine
OncoTargets and Therapy.  10 (2017)  - p. 1295-1305 , 2017
Link: https://doi.org/10.2147/..
 
?
14

NADIR: A Non-Interventional Study on the Prophylaxis of Che..:

Kurbacher, Christian M. ; Fietz, Thomas ; Diel, Ingo J....
Oncology Research and Treatment.  38 (2015)  5 - p. 221-229 , 2015
Link: https://doi.org/10.1159/..
 
?
15

Biosimilar Epoetin Zeta in Oncology and Haematology: Develo..:

Michallet, Mauricette ; Losem, Christoph
Acta Haematologica.  135 (2015)  1 - p. 44-52 , 2015
Link: https://doi.org/10.1159/..
 
1-15